Compare AMAR REMEDIES with Hindustan Unilever - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAR REMEDIES vs HUL - Comparison Results

HUL 
   Change

HUL, the largest FMCG company in the country constitutes 13% of the industry valued at Rs. 1.6 trillion (AC Nielsen). It is present in over 20 distinct categories in Home & Personal Care Products and Foods & Beverages. Revenue share of the various pr... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AMAR REMEDIES HUL AMAR REMEDIES/
HUL
 
P/E (TTM) x -0.5 73.9 - View Chart
P/BV x 0.1 63.1 0.1% View Chart
Dividend Yield % 0.0 1.0 -  

Financials

 AMAR REMEDIES   HUL
EQUITY SHARE DATA
    AMAR REMEDIES
Jun-12
HUL
Mar-20
AMAR REMEDIES/
HUL
5-Yr Chart
Click to enlarge
High Rs1642,312 7.1%   
Low Rs861,650 5.2%   
Sales per share (Unadj.) Rs261.6183.8 142.3%  
Earnings per share (Unadj.) Rs17.431.2 55.7%  
Cash flow per share (Unadj.) Rs22.335.9 62.1%  
Dividends per share (Unadj.) Rs025.00 0.0%  
Dividend yield (eoy) %01.3 0.0%  
Book value per share (Unadj.) Rs100.738.0 264.9%  
Shares outstanding (eoy) m26.162,164.53 1.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.510.8 4.4%   
Avg P/E ratio x7.263.4 11.3%  
P/CF ratio (eoy) x5.655.2 10.2%  
Price / Book Value ratio x1.252.1 2.4%  
Dividend payout %080.0 0.0%   
Avg Mkt Cap Rs m3,2704,287,501 0.1%   
No. of employees `000NA7.1 0.0%   
Total wages/salary Rs m16318,200 0.9%   
Avg. sales/employee Rs ThNM56,174.8-  
Avg. wages/employee Rs ThNM2,569.9-  
Avg. net profit/employee Rs ThNM9,551.0-  
INCOME DATA
Net Sales Rs m6,844397,830 1.7%  
Other income Rs m216,320 0.3%   
Total revenues Rs m6,865404,150 1.7%   
Gross profit Rs m1,13198,610 1.1%  
Depreciation Rs m12810,020 1.3%   
Interest Rs m3981,180 33.7%   
Profit before tax Rs m62693,730 0.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-50-2,000 2.5%   
Tax Rs m12124,090 0.5%   
Profit after tax Rs m45567,640 0.7%  
Gross profit margin %16.524.8 66.7%  
Effective tax rate %19.325.7 75.2%   
Net profit margin %6.617.0 39.1%  
BALANCE SHEET DATA
Current assets Rs m4,904123,210 4.0%   
Current liabilities Rs m3,58193,170 3.8%   
Net working cap to sales %19.37.6 256.0%  
Current ratio x1.41.3 103.6%  
Inventory Days Days12425 489.5%  
Debtors Days Days10011 950.1%  
Net fixed assets Rs m1,68960,760 2.8%   
Share capital Rs m2622,160 12.1%   
"Free" reserves Rs m2,35880,130 2.9%   
Net worth Rs m2,63582,290 3.2%   
Long term debt Rs m5070-   
Total assets Rs m6,862201,530 3.4%  
Interest coverage x2.680.4 3.2%   
Debt to equity ratio x0.20-  
Sales to assets ratio x1.02.0 50.5%   
Return on assets %12.434.1 36.4%  
Return on equity %17.382.2 21.0%  
Return on capital %31.0112.9 27.5%  
Exports to sales %4.00-   
Imports to sales %00-   
Exports (fob) Rs m273NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m2732,830 9.6%   
Fx outflow Rs m215,650 0.0%   
Net fx Rs m271-12,820 -2.1%   
CASH FLOW
From Operations Rs m-31376,230 -0.4%  
From Investments Rs m-48917,910 -2.7%  
From Financial Activity Rs m769-68,190 -1.1%  
Net Cashflow Rs m-3325,950 -0.1%  

Share Holding

Indian Promoters % 25.5 0.0 -  
Foreign collaborators % 0.0 67.3 -  
Indian inst/Mut Fund % 9.2 4.1 224.4%  
FIIs % 0.0 14.1 -  
ADR/GDR % 0.0 0.0 -  
Free float % 65.3 14.5 450.3%  
Shareholders   13,061 322,351 4.1%  
Pledged promoter(s) holding % 99.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AMAR REMEDIES With:   RELAXO FOOTWEARS  K.S.OILS  COLGATE  KARUTURI GLOBAL  GODREJ INDUSTRIES  

Compare AMAR REMEDIES With:   UNILEVER PLC. (UK)  P&G (US)  HYPERMARCAS (Brazil)  



Today's Market

Sensex Tanks 531 Points; Reliance Industries & IndusInd Bank Fall 5%(Closing)

Indian share markets witnessed huge selling pressure today and failed to hold on to their opening gains as profit booking and weakness across all sectors erased gains.

Related Views on News

HUL Announces Quarterly Results (2QFY21); Net Profit Up 8.7% (Quarterly Result Update)

Oct 21, 2020 | Updated on Oct 21, 2020

For the quarter ended September 2020, HUL has posted a net profit of Rs 20 bn (up 8.7% YoY). Sales on the other hand came in at Rs 114 bn (up 16.1% YoY). Read on for a complete analysis of HUL's quarterly results.

HUL 2019-20 Annual Report Analysis (Annual Result Update)

Aug 6, 2020 | Updated on Aug 6, 2020

Here's an analysis of the annual report of HUL for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of HUL. Also includes updates on the valuation of HUL.

HUL Announces Quarterly Results (1QFY21); Net Profit Up 7.2% (Quarterly Result Update)

Jul 22, 2020 | Updated on Jul 22, 2020

For the quarter ended June 2020, HUL has posted a net profit of Rs 19 bn (up 7.2% YoY). Sales on the other hand came in at Rs 106 bn (up 4.4% YoY). Read on for a complete analysis of HUL's quarterly results.

HUL Announces Quarterly Results (4QFY20); Net Profit Down 1.2% (Quarterly Result Update)

May 4, 2020 | Updated on May 4, 2020

For the quarter ended March 2020, HUL has posted a net profit of Rs 15 bn (down 1.2% YoY). Sales on the other hand came in at Rs 90 bn (down 9.4% YoY). Read on for a complete analysis of HUL's quarterly results.

HUL Announces Quarterly Results (3QFY20); Net Profit Up 11.9% (Quarterly Result Update)

Feb 1, 2020 | Updated on Feb 1, 2020

For the quarter ended December 2019, HUL has posted a net profit of Rs 16 bn (up 11.9% YoY). Sales on the other hand came in at Rs 98 bn (up 2.6% YoY). Read on for a complete analysis of HUL's quarterly results.

More Views on News

Most Popular

Time to Book Profits in Pharma Stocks(Fast Profits Daily)

Jan 15, 2021

In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.

Smallcap Stocks: Your Best Bet for 2021 and Beyond(Profit Hunter)

Jan 15, 2021

The pandemic failed to thwart Richa's investing success formula for 2020.

One Chart to See Before You Sell(Fast Profits Daily)

Jan 22, 2021

In this video, I'll show you a crucial chart that you need to check before you decide to sell any stock or index.

Invest in the Multibaggers of 2021 and Beyond(Profit Hunter)

Jan 21, 2021

Our ace stock picker is ready to capitalise on a big growth opportunity.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

AMAR REMEDIES SHARE PRICE


Dec 11, 2013 (Close)

TRACK AMAR REMEDIES

  • Track your investment in AMAR REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AMAR REMEDIES 5-YR ANALYSIS

COMPARE AMAR REMEDIES WITH

MARKET STATS